Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug;9(4):396-407.
doi: 10.1177/1740774512450098. Epub 2012 Jul 2.

Including all individuals is not enough: lessons for intention-to-treat analysis

Affiliations

Including all individuals is not enough: lessons for intention-to-treat analysis

Ian R White et al. Clin Trials. 2012 Aug.

Abstract

Background: Intention-to-treat (ITT) analysis requires all randomised individuals to be included in the analysis in the groups to which they were randomised. However, there is confusion about how ITT analysis should be performed in the presence of missing outcome data.

Purposes: To explain, justify, and illustrate an ITT analysis strategy for randomised trials with incomplete outcome data.

Methods: We consider several methods of analysis and compare their underlying assumptions, plausibility, and numbers of individuals included. We illustrate the ITT analysis strategy using data from the UK700 trial in the management of severe mental illness.

Results: Depending on the assumptions made about the missing data, some methods of analysis that include all randomised individuals may be less valid than methods that do not include all randomised individuals. Furthermore, some methods of analysis that include all randomised individuals are essentially equivalent to methods that do not include all randomised individuals.

Limitations: This work assumes that the aim of analysis is to obtain an accurate estimate of the difference in outcome between randomised groups and not to obtain a conservative estimate with bias against the experimental intervention.

Conclusions: Clinical trials should employ an ITT analysis strategy, comprising a design that attempts to follow up all randomised individuals, a main analysis that is valid under a stated plausible assumption about the missing data, and sensitivity analyses that include all randomised individuals in order to explore the impact of departures from the assumption underlying the main analysis. Following this strategy recognises the extra uncertainty arising from missing outcomes and increases the incentive for researchers to minimise the extent of missing data.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean profiles in one arm of a hypothetical randomised trial for individuals who have complete data (solid line) and those who drop out at time 1 (dashed line), illustrating three possible assumptions for missing data at time 2 (dotted line).
Figure 2
Figure 2
Mean profiles in one arm of a hypothetical randomised trial for individuals who have complete data (solid line) and those who drop out at time 1 (dashed line), showing how LOCF and MCAR can agree without necessarily being correct.
Figure 3
Figure 3
UK700 trial: sensitivity analysis for departures from MAR. The basic analysis is the mixed model with CPRS as outcome and baseline CPRS as covariate using available cases. The parameter δ is the difference between missing and observed CPRS, adjusted for baseline CPRS, in one or both arms. Vertical bars are 95% confidence intervals.

References

    1. Newell DJ. Intention-to-treat analysis: implications for quantitative and qualitative research. International Journal of Epidemiology. 1992;21:837–841. - PubMed
    1. McKnight P, McKnight KM, Sidani S, Figueredo AJ. Missing data: A gentle introduction. The Guilford Press; New York: 2007.
    1. PSI Missing Data Expert Group. Missing data: Discussion points from the PSI missing data expert group. Pharmaceutical Statistics. 2009 doi: 10.1002/pst.391. - DOI - PubMed
    1. National Research Council. The Prevention and Treatment of Missing Data in Clinical Trials. The National Academies Press; Washington, DC: 2010. Panel on Handling Missing Data in Clinical Trials Committee on National Statistics, Division of Behavioral and Social Sciences and Education.
    1. Little RJA, Rubin DB. Statistical Analysis with Missing Data. 2nd Wiley; Hoboken, N. J.: 2002.

Publication types

LinkOut - more resources